Category: <span>mesothelioma</span>

Category: mesothelioma

Clinical Trials/Research/Emerging Treatments, mesothelioma, Mesothelioma News, Treatment

New Drug to Treat Mesothelioma Hailed as a Major Breakthrough

 

ADI-PEG20 or pegargiminase is being hailed as the first drug of its kind to be incorporated successfully with chemotherapy in 20 years. Researchers say this new drug could bring hope to thousands of mesothelioma survivors and their families.  The drug blocks the cancer’s food supply, ensuring the disease can’t spread. It prevents cancer cells from […]

The post New Drug to Treat Mesothelioma Hailed as a Major Breakthrough appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, mesothelioma, Mesothelioma News, Treatment

FDA Fast Tracks UV1 Vaccine Combo for Mesothelioma

 

The U.S. Food and Drug Administration granted fast-track designation to a new therapeutic cancer vaccine. The approval is for UV1 in combination with the immunotherapy drugs Opdivo (nivolumab) and Yervoy (ipilimumab) to manage malignant pleural mesothelioma that can’t be managed with surgery.  Therapeutic cancer vaccines, unlike preventive vaccines, treat existing cancers. Fast Track expedites the […]

The post FDA Fast Tracks UV1 Vaccine Combo for Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos exposure, Clinical Trials/Research/Emerging Treatments, Doctors/Specialists, mesothelioma, Mesothelioma News

Early Detection Tests for Mesothelioma Are in Development

 

Scientists in Australia are developing early detection tests for mesothelioma. The Asbestos and Dust Diseases Research Institute’s new test could potentially save lives. According to ADDRI’s academic and research director Dr. Anthony Linton, the tests will be similar to PCR tests already in use to detect COVID-19. These new tests can find small amounts of […]

The post Early Detection Tests for Mesothelioma Are in Development appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos exposure, Clinical Trials/Research/Emerging Treatments, Doctors/Specialists, mesothelioma, Mesothelioma News

Early Detection Tests for Mesothelioma Are in Development

 

Scientists in Australia are developing early detection tests for mesothelioma. The Asbestos and Dust Diseases Research Institute’s new test could potentially save lives. According to ADDRI’s academic and research director Dr. Anthony Linton, the tests will be similar to PCR tests already in use to detect COVID-19. These new tests can find small amounts of […]

The post Early Detection Tests for Mesothelioma Are in Development appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos (general), asbestos exposure, Awareness/Advocacy, mesothelioma, Mesothelioma News, Support/Support Groups/Organizations

Nonprofit Teams With Firefighter Union for Asbestos Ban Campaign

 

The Asbestos Disease Awareness Organization is teaming with the International Association of Fire Fighters on a new anti-asbestos campaign. In a continued push toward a national ban of the toxic mineral, the organizations have created a 120 foot high and 84 foot wide billboard in New York City’s Times Square. A firefighter in full gear […]

The post Nonprofit Teams With Firefighter Union for Asbestos Ban Campaign appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos (general), asbestos exposure, Awareness/Advocacy, mesothelioma, Mesothelioma News, Support/Support Groups/Organizations

Nonprofit Teams With Firefighter Union for Asbestos Ban Campaign

 

The Asbestos Disease Awareness Organization is teaming with the International Association of Fire Fighters on a new anti-asbestos campaign. In a continued push toward a national ban of the toxic mineral, the organizations have created a 120 foot high and 84 foot wide billboard in New York City’s Times Square. A firefighter in full gear […]

The post Nonprofit Teams With Firefighter Union for Asbestos Ban Campaign appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, Immunotherapy, mesothelioma, Mesothelioma News

Phase I Trial Improves Mesothelioma Survival More Than 200%

 

Sellas Life Sciences reports its Phase I clinical trial showed improvement of overall survival in patients with pleural mesothelioma. The study focused on a new potential therapy called GPS (galinpepimut-S), an immunotherapy vaccine. The trial included 10 patients with relapsed or refractory mesothelioma, nine of whom received at least three doses of GPS. Researchers gave […]

The post Phase I Trial Improves Mesothelioma Survival More Than 200% appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, Immunotherapy, mesothelioma, Mesothelioma News

Early Mesothelioma Vaccine Testing Shows Promise

 

Sellas Life Sciences reports its Phase I clinical trial showed improvement of overall survival in patients with pleural mesothelioma. The study focused on a new potential therapy called GPS (galinpepimut-S), an immunotherapy vaccine. The trial included 10 patients with relapsed or refractory mesothelioma, nine of whom received at least three doses of GPS. Researchers gave […]

The post Early Mesothelioma Vaccine Testing Shows Promise appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos (general), asbestos exposure, Companies, Legal, mesothelioma, Mesothelioma News, Secondary Exposure, talc, Talcum powder, verdict

$30M Mesothelioma Verdict Awarded in Case Against Bridgestone

 

An Illinois jury has awarded $30 million in a mesothelioma case against tiremaker Bridgestone Firestone. Thomas Jackson was exposed to asbestos inadvertently brought home from his father’s job at one of the company’s tire manufacturing plants. Jackson died just five weeks after his mesothelioma diagnosis at 64 years old. Attorneys for Jackson’s wife, Dorothy Jackson, […]

The post $30M Mesothelioma Verdict Awarded in Case Against Bridgestone appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos (general), asbestos exposure, Companies, Legal, mesothelioma, Mesothelioma News, Secondary Exposure, talc, Talcum powder, verdict

$30M Mesothelioma Verdict Awarded in Case Against Bridgestone

 

An Illinois jury has awarded $30 million in a mesothelioma case against tiremaker Bridgestone Firestone. Thomas Jackson was exposed to asbestos inadvertently brought home from his father’s job at one of the company’s tire manufacturing plants. Jackson died just five weeks after his mesothelioma diagnosis at 64 years old. Attorneys for Jackson’s wife, Dorothy Jackson, […]

The post $30M Mesothelioma Verdict Awarded in Case Against Bridgestone appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos (general), asbestos exposure, johnson, Litigation, mesothelioma, Mesothelioma News, settlement

J&J to Pay $700 Million to Settle Talc Baby Powder Investigation

 

Johnson & Johnson’s $700 million deal will resolve a talcum powder investigation a group of 43 State Attorneys Generals launched. J&J is accused of not warning people about potential health risks linked to its talc-based baby powder.  This latest settlement won’t resolve thousands of other lawsuits that claim the company’s talc-based products cause cancer. In […]

The post J&J to Pay $700 Million to Settle Talc Baby Powder Investigation appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos (general), asbestos exposure, johnson, Litigation, mesothelioma, Mesothelioma News, settlement

J&J to Pay $700 Million to Settle Talc Baby Powder Investigation

 

Johnson & Johnson’s $700 million deal will resolve a talcum powder investigation a group of 43 State Attorneys Generals launched. J&J is accused of not warning people about potential health risks linked to its talc-based baby powder.  This latest settlement won’t resolve thousands of other lawsuits that claim the company’s talc-based products cause cancer. In […]

The post J&J to Pay $700 Million to Settle Talc Baby Powder Investigation appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos (general), asbestos exposure, asbestosis, Lung Cancer (Non-Meso), mesothelioma, Mesothelioma News

Study: Fibers Released from Asbestos Cement Far Exceed Limits

 

The installation and removal of asbestos cement products may put workers at significant health risks, according to a recent study published in the Annals of Work Exposures and Health. The nonprofit organization Occupational Knowledge International found that exposure levels to airborne asbestos exceed the short-term limit created by the Occupational Safety and Health Administration.  Exposure […]

The post Study: Fibers Released from Asbestos Cement Far Exceed Limits appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos (general), asbestos exposure, asbestosis, Lung Cancer (Non-Meso), mesothelioma, Mesothelioma News

Study: Fibers Released from Asbestos Cement Far Exceed Limits

 

The installation and removal of asbestos cement products may put workers at significant health risks, according to a recent study published in the Annals of Work Exposures and Health. The nonprofit organization Occupational Knowledge International found that exposure levels to airborne asbestos exceed the short-term limit created by the Occupational Safety and Health Administration.  Exposure […]

The post Study: Fibers Released from Asbestos Cement Far Exceed Limits appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, mesothelioma, Mesothelioma News, Treatment

Polaris Submits Application for New Mesothelioma Treatment

 

Multinational biopharmaceutical company Polaris Group announced their application for a rolling submission of a new mesothelioma treatment this month. The Biologic License Application for the experimental drug ADI-PEG 20 is the first step in U.S. Food and Drug Administration approval.  The application outlines the use of ADI-PEG 20 for non-epithelioid mesothelioma alongside treatment with pemetrexed […]

The post Polaris Submits Application for New Mesothelioma Treatment appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.